Kubaski, Francyne

Staff Scientist

Kubaski, Francyne

Dr. Kubaski joined Greenwood Genetic Center as a staff scientist in the Biochemical Genetics Laboratory in 2021. Dr. Kubaski has been involved with research for inborn errors of metabolism (IEM), and most specifically lysosomal storage disorders (LSD), within the last 10 years and she has been working with the application of ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) for diagnosis, treatment monitoring, and newborn screening of these disorders.
In the Biochemical Genetics laboratory, Dr. Kubaski will work with method development for a variety of metabolites that can be used for diagnosis, monitoring, and screening of our patients for these diseases by UPLC-MS/MS.

Contact Information

Office (864) 953-3985
Fax (864) 941-8133
fkubaski@ggc.org

Education

  • B.S., Biomedical Sciences, IESA, 2010
  • Masters in Medicine: Medical Sciences, Universidade Federal do Rio Grande do Sul, 2012
  • Ph.D in Biological Sciences, Molecular Biology & Genetics, University of Delaware, 2017
  • Post-doctoral fellow, Molecular Biology & Genetics, Universidade Federal do Rio Grande do Sul, 2021

Awards

Dr. Kubaski was awarded the Young Investigator award in 2017 and 2019 by the Annual WORLDSymposium™. In 2017, she has also been awarded the Theodore Wolf Prize- Outstanding Dissertation in the Physical and Life Sciences (Animal and Food Sciences, Applied Physiology, Bioinformatics, Biological Sciences, Chemistry & Biochemistry, Climatology, Entomology & Wildlife Ecology, Geography, Geology, Marine Studies, Nursing Science, Oceanography, Plant & Soil Sciences and Physics) from the University of Delaware (Dissertation title: Diagnosis and therapies for Mucopolysaccharidoses). And in 2020, Dr. Kubaski was honored with the Jean Dussault Medal from the International Society for Neonatal Screening that recognizes outstanding young investigators who have made a significant contribution to neonatal or other population-based screening.

Selected Publications

  • Kubaski, F.; Herbst, Z.M.; Burin, M.G.; Michelin-Tirelli, K.; Trapp, F.B.; Gus, R.; Netto, A.B.O.; Brusius-Facchin, A.C.; Leistner-Segal, S.; Sanseverino, M.T.; Souza, C.M.F.; Wilke, M.V.M.B; Oliveira, T.; Magalhaes, J.A.A.; Giugliani, R. (2022) Measurement of sulfatides in the amniotic fluid supernatant: a useful tool in the prenatal diagnosis of metachromatic leukodystrophy. JIMDR in press
  • Kubaski, F.; Herbst, Z. M..; Pereira, D.A.A.; Silva, C.; Chen, C.; Hwu, P.W.L.; van der Linden, H.; Lourenço, C.M.; Giugliani, R. (2021) Evaluation of 3-O-methyldopa as a biomarker for aromatic L-amino acid decarboxylase deficiency in 7 Brazilian cases. MGMR 27:1-4.
  • Kubaski, F.; Sousa, I.; Amorim, T.; Pereira, D.; Trometer, J.; Souza, A.; Ranieri, E.; Polo, G.; Burlina, A.; Brusius-Facchin, A.C.; Netto, A.B.O.; Tomatsu, S.; Giugliani, R. (2020) Neonatal Screening for MPS Disorders in Latin America: A survey of pilot initiatives. Int. J. Neonatal Screen 6,90:1-10.
  • Kubaski, F.; de Oliveira Poswar, F.; Michelin-Tirelli, K.; Graeff, M.B.; Málaga, D.R.; Brusius-Facchin, A.C.; Leistner-Segal, S.; Giugliani, R. (2020). Diagnosis of Mucopolysaccharidoses. Diagnostics 10(3), 162.
  • Schuh, R.; Gonzalez, E.; Tavares, A.; Seolin, B.; Elias, L.; Vera, L.P.; Kubaski, F.; Poletto, E.; Giugliani, R.; Matte, U.; Teixeira, H.; Baldo, G. (2020). Neonatal nonviral gene editing with the CRISPR/Cas9 system improves cardiovascular, respiratory, and bone disease in mucopolysaccharidosis I mice. Gene Therapy 27, (1-2):74-84.
  • Vairo, F.P.; Malaga, D.R.; Kubaski, F.; de Souza, C.F.M.; Poswar, F.O.; Baldo, G.; Giugliani, R. (2020). Precision medicine for lysosomal disorders. Biomolecules 10, 1110.
  • Giugliani, R.; Vairo, F.; Kubaski, F.; Poswar, F.; Riegel, M.; Baldo, G.; Saute, J.A. (2018). Neurological manifestations of lysosomal storage disorders and emerging therapies targeting the CNS. The lancet child and adol 2(1): 56-68.
  • Kubaski, F.; Yabe, H.; Suzuki, Y.; Seto, T.; Hamazaki, T.; Mason, R.W.; Xie, L.; Onsten, T.G.H.; Leistner-Segal, S.; Giugliani, R.; Dung, V.C.; Ngoc, C.T.B.; Yamaguchi, S.; Montaño, A.M.; Orii, K.E.; Fukao, T.; Shintaku, H.; Orii, T.; Tomatsu, S. (2017). Hematopoietic stem cell transplantation for patients with Mucopolysaccharidosis II. Biol. Blood Marrow Transplant 23(10): 1795-1803.
  • Kubaski, F.; Mason, R.W.; Nakatomi, A.; Shinatku, H.; Xie, L.; van Vlies, N.N.; Church, H.; Giugliani, R.; Kobayashi, H.; Yamaguchi, S.; Suzuki, Y.; Orii, T.; Fukao, T.; Montaño, A.M.; Tomatsu, S. (2016) Newborn screening for mucopolysaccharidosis: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry. J. Inherit. Metab. Dis. 40(1): 151-8.
  • Kubaski, F.; Osago, H.; Mason, R.W.; Yamaguchi, S.; Kobayashi, H.; Tsuchiya, M.; Orii, T.; Tomatsu, S. (2016) Glycosaminoglycans detection methods: applications of mass spectrometry. Mol. Genet. Metab. 120 (1-2): 67-77.
  • Kubaski, F.; Suzuki, Y.; Orii, K.; Giugliani, R.; Church, HJ.; Mason, RW.; Dũng, VC.; Ngoc CT.; Yamaguchi, S.; Kobayashi, H.; Girisha, KM.; Fukao, T.; Orii, T.; Tomatsu, S. (2016). Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses. Mol. Genet. Metab. 120(3): 247-54.

Meet Reggie Roper

Reggie has been part of the GGC family for over 18 years. He has short stature, webbing of his hands, pulmonary stenosis, seizures and hydrocephalus along with developmental delay. He carried an initial diagnosis of cardiofaciocutaneous (CFC) syndrome; however, as genetic testing advanced, GGC made the diagnosis of Noon...

In The News